Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 13 2024
0mins
Source: Benzinga
Eli Lilly's Stock Performance: Eli Lilly has seen a year-to-date increase of 32.11%, impacting various ETFs differently, with some experiencing gains and others declines in their YTD performance.
Strategic Investments and Growth Plans: The company announced a $15 billion share buyback and a $3 billion expansion of its manufacturing facility as part of a broader $23 billion investment to enhance production capabilities for diabetes and obesity treatments.
Analyst Views on THNR
Wall Street analysts forecast THNR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THNR is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 26.051
Low
Averages
High
Current: 26.051
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
